Veeva Systems Inc. (VEEV)
USD 226.67
(2.78%)
USD 226.67
(2.78%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 5.91 Billion USD | 23.03% |
| 2023 | 4.8 Billion USD | 25.88% |
| 2022 | 3.81 Billion USD | 25.29% |
| 2021 | 3.04 Billion USD | 34.08% |
| 2020 | 2.27 Billion USD | 37.37% |
| 2019 | 1.65 Billion USD | 37.76% |
| 2018 | 1.2 Billion USD | 30.81% |
| 2017 | 917.7 Million USD | 30.02% |
| 2016 | 705.79 Million USD | 29.53% |
| 2015 | 544.89 Million USD | 47.15% |
| 2014 | 370.3 Million USD | 312.28% |
| 2013 | 89.82 Million USD | 116.88% |
| 2012 | 41.41 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 5.22 Billion USD | -0.05% |
| 2024 Q4 | 5.91 Billion USD | 13.11% |
| 2024 FY | 5.91 Billion USD | 23.03% |
| 2024 Q1 | 5.02 Billion USD | 4.56% |
| 2024 Q2 | 5.22 Billion USD | 4.08% |
| 2023 Q2 | 4.11 Billion USD | 2.63% |
| 2023 FY | 4.8 Billion USD | 25.88% |
| 2023 Q4 | 4.8 Billion USD | 14.86% |
| 2023 Q3 | 4.18 Billion USD | 1.61% |
| 2023 Q1 | 4.01 Billion USD | 5.1% |
| 2022 Q2 | 3.35 Billion USD | 4.01% |
| 2022 Q4 | 3.81 Billion USD | 13.33% |
| 2022 FY | 3.81 Billion USD | 25.29% |
| 2022 Q1 | 3.22 Billion USD | 5.78% |
| 2022 Q3 | 3.36 Billion USD | 0.48% |
| 2021 FY | 3.04 Billion USD | 34.08% |
| 2021 Q4 | 3.04 Billion USD | 17.9% |
| 2021 Q3 | 2.58 Billion USD | 2.67% |
| 2021 Q2 | 2.51 Billion USD | 4.65% |
| 2021 Q1 | 2.4 Billion USD | 5.85% |
| 2020 Q4 | 2.27 Billion USD | 19.54% |
| 2020 Q3 | 1.9 Billion USD | 2.18% |
| 2020 Q1 | 1.77 Billion USD | 7.4% |
| 2020 FY | 2.27 Billion USD | 37.37% |
| 2020 Q2 | 1.85 Billion USD | 4.72% |
| 2019 Q4 | 1.65 Billion USD | 18.36% |
| 2019 FY | 1.65 Billion USD | 37.76% |
| 2019 Q3 | 1.39 Billion USD | 2.4% |
| 2019 Q2 | 1.36 Billion USD | 3.56% |
| 2019 Q1 | 1.31 Billion USD | 9.76% |
| 2018 Q4 | 1.2 Billion USD | 14.75% |
| 2018 FY | 1.2 Billion USD | 30.81% |
| 2018 Q1 | 996.19 Million USD | 8.55% |
| 2018 Q2 | 1.03 Billion USD | 3.98% |
| 2018 Q3 | 1.04 Billion USD | 1.0% |
| 2017 Q2 | 787.23 Million USD | 4.71% |
| 2017 Q3 | 788.47 Million USD | 0.16% |
| 2017 Q4 | 917.7 Million USD | 16.39% |
| 2017 FY | 917.7 Million USD | 30.02% |
| 2017 Q1 | 751.79 Million USD | 6.52% |
| 2016 FY | 705.79 Million USD | 29.53% |
| 2016 Q3 | 625.03 Million USD | 5.65% |
| 2016 Q2 | 591.63 Million USD | 4.04% |
| 2016 Q1 | 568.66 Million USD | 4.36% |
| 2016 Q4 | 705.79 Million USD | 12.92% |
| 2015 Q4 | 544.89 Million USD | 10.63% |
| 2015 FY | 544.89 Million USD | 47.15% |
| 2015 Q1 | 435.12 Million USD | 17.5% |
| 2015 Q3 | 492.55 Million USD | 6.1% |
| 2015 Q2 | 464.24 Million USD | 6.69% |
| 2014 Q1 | 103.38 Million USD | 15.1% |
| 2014 Q4 | 370.3 Million USD | 7.25% |
| 2014 FY | 370.3 Million USD | 312.28% |
| 2014 Q3 | 345.28 Million USD | 206.6% |
| 2014 Q2 | 112.62 Million USD | 8.94% |
| 2013 FY | 89.82 Million USD | 116.88% |
| 2013 Q4 | 89.82 Million USD | 0.0% |
| 2012 FY | 41.41 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| American Well Corporation | 589.7 Million USD | -902.352% |
| Doximity, Inc. | 1.07 Billion USD | -447.625% |
| Evolent Health, Inc. | 2.68 Billion USD | -120.531% |
| MultiPlan Corporation | 7.1 Billion USD | 16.814% |
| Phreesia, Inc. | 371.08 Million USD | -1492.875% |
| Teladoc Health, Inc. | 4.39 Billion USD | -34.572% |